5 Common Myths About Medication-Assisted Treatment — Debunked
Dr. Marcus Webb, PharmD
Clinical Pharmacist
Medication-Assisted Treatment (MAT) combines FDA-approved medications — such as buprenorphine, naltrexone, and methadone — with behavioral therapy to treat opioid and alcohol use disorders. Despite overwhelming evidence of its effectiveness, misconceptions persist.
Myth 1: "MAT just replaces one drug with another."
Fact: MAT medications are prescribed at precise, therapeutic doses under medical supervision. They stabilize brain chemistry, reduce cravings, and block the euphoric effects of opioids — they do not produce intoxication when taken as directed.
Myth 2: "You're not really in recovery if you take medication."
Fact: The American Society of Addiction Medicine, SAMHSA, and every major medical organization define recovery by improved functioning and quality of life — not by the absence of medication. We don't ask diabetics to go off insulin to prove they're healthy.
Myth 3: "MAT is only for heroin users."
Fact: MAT is FDA-approved for opioid use disorder (including prescription pain pill addiction) and alcohol use disorder. Newer protocols are also showing promise for stimulant use disorders.
Myth 4: "You have to be on medication forever."
Fact: Duration of MAT is individualized. Some patients stabilize and taper off within months; others benefit from long-term maintenance. Both are valid medical decisions made collaboratively with a provider.
Myth 5: "MAT doesn't work without in-person visits."
Fact: Telemedicine MAT (teleMAT) has been rigorously studied and shown to improve retention in treatment by removing travel, stigma, and schedule barriers. At Better Tomorrow, all MAT services are delivered virtually.